旁观者效应
艾瑞布林
医学
药理学
癌症研究
内科学
癌症
乳腺癌
转移性乳腺癌
免疫学
作者
Yang Wang,Bing Xia,Lixia Cao,Jianfeng Yang,Feng Cui,Fangdun Jiang,Chen Li,Lixia Gu,Yifan Yang,Tian Jing,Xin Cheng,Keiji Furuuchi,James Fulmer,Arielle Verdi,Katherine A. Rybinski,Allis Soto,Earl F. Albone,Toshimitsu Uenaka,Likun Gong,Tingting Liu
摘要
The preclinical data support the test of BB-1701 in patients with various HER2-expressing cancers, including those resistant to other HER2-targeting ADCs. A phase I clinical trial of BB-1701 (NCT04257110) in patients is currently underway.
科研通智能强力驱动
Strongly Powered by AbleSci AI